"Poor Things," "The Last of Us" and "Jack Ryan" also among honorees The post ‘Oppenheimer’ and ‘The Bear’ Win At Inaugural ...
Oppenheimer started coverage of Dianthus Therapeutics (DNTH) with an outperform rating, citing the market potential of its ...
The show's creator (Oppenheimer) and its newest star (Ellis) tell PEOPLE that "it's strange that it isn't strange" to work ...
Stocks to Watch. In this article, we are going to take a look at where Lowe’s Companies Inc. (NYSE:LOW) stands against the ...
Fintel on MSN1d
Oppenheimer Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right (LGNZZ) with Outperform RecommendationFintel reports that on October 3, 2024, Oppenheimer initiated coverage of Ligand Pharmaceuticals Incorporated - Equity Right ...
Oppenheimer analyst Scott Schneeberger maintained a Buy rating on XPO (XPO – Research Report) today and set a price target of $140.00.
Cillian Murphy once shared his “Catholic guilt” for making $10 million from Christopher Nolan’s Oppenheimer, admitting he ...
Oppenheimer analyst Ian Zaffino maintained a Buy rating on Talen Energy Corp (TLN – Research Report) today and set a price target of ...
We look at prior dramatizations of this very complicated man—including one wherein J. Robert Oppenheimer played himself!—and examine why they worked or didn't. In this episode: ...
We look at prior dramatizations of this very complicated man—including one wherein J. Robert Oppenheimer played himself!—and examine why they worked or didn't. In the episode: ...
BridgeBio Pharma BBIO) stock received a Perform rating from Oppenheimer on market challenges to its late-stage assets acoramidis and infigratinib. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback